Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-Term Treatment of Collagenous Colitis With Budesonide
NCT00139165Phase 3Unknown
- Start
- Sep 2004
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of EPI-EE in collagenous colitis (CC) (2 arms). Primary endpoint: Clinical symptoms (number of daily stools). Status: unknown.
02
Drugs
EPI-EE
03
Conditions
collagenous colitis (CC)
Beyond the preview
Go deeper on NCT00139165.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00139165.